SRTS - Sensus Healthcare, Inc.
IEX Last Trade
7.23
-0.160 -2.213%
Share volume: 5,335
Last Updated: Thu 26 Dec 2024 08:30:13 PM CET
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
$7.39
-0.16
-2.17%
Fundamental analysis
29%
Profitability
6%
Dept financing
6%
Liquidity
74%
Performance
45%
Performance
5 Days
-1.02%
1 Month
-21.02%
3 Months
18.26%
6 Months
35.19%
1 Year
172.00%
2 Year
-1.45%
Key data
Stock price
$7.23
DAY RANGE
$6.88 - $7.39
52 WEEK RANGE
$2.44 - $9.33
52 WEEK CHANGE
$183.33
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Joseph C. Sardano
Region: US
Website: sensushealthcare.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: sensushealthcare.com
Employees: 40
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Sensus Healthcare, Inc. manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. SRT-100 is an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers.
Recent news